Transaction in Own Shares

Summary by AI BETAClose X

CVS Group plc has purchased 11,110 ordinary shares at prices ranging from 1,264.00 pence to 1,274.00 pence, with a volume-weighted average price of 1,271.04 pence, as part of its ongoing share buyback program. These shares will be cancelled, reducing the total number of issued ordinary shares to 70,742,004. Since the program's inception, CVS has repurchased 998,779 shares at a weighted average price of 1,219.39 pence.

Disclaimer*

CVS Group plc
24 December 2025
 

24 December 2025

 

CVS GROUP plc

("CVS" or the "Company" and, together with its subsidiaries, the "Group")

Transaction in own shares

 

CVS announces that on 23 December 2025 it purchased the following number of its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg, Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the terms of the share buyback programme announced on 24 October 2025 (the "Share Buyback Programme").

 

Date of purchase:

23/12/2025

Aggregate number of Ordinary Shares purchased:

11,110

Lowest price paid per share (GBp):

1,264.00

Highest price paid per share (GBp):

1,274.00

Volume weighted average price paid per share (GBp):

1,271.04


CVS intends to cancel all of the purchased Ordinary Shares.

 

Following settlement of the above purchases and cancellation of the Ordinary Shares purchased, CVS will have 70,742,004 Ordinary Shares in issue and holds no Ordinary Shares in treasury.

 

The total number of voting rights in CVS is therefore 70,742,004 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, CVS under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Since the commencement of the Share Buyback Programme, the Company has repurchased 998,779 Ordinary Shares in aggregate at a weighted average price of 1,219.39 pence per share.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), as it forms part of Retained EU Law as defined in the European Union (Withdrawal) Act 2018, the table below contains detailed information of the individual trades made by Berenberg as part of the Share Buyback Programme.

 

Individual transactions:

 

Number of

Ordinary Shares purchased

Transaction price (GBp share)

Time of

transaction (UK Time)

Transaction

reference number

Trading Venue

 


312

1272

23/12/2025 08:08:50

1357029960584123

XLON


57

1272

23/12/2025 08:08:50

1357029960584124

XLON


226

1266

23/12/2025 08:21:27

1357029960585937

XLON


44

1264

23/12/2025 09:22:14

1357029960589904

XLON


6

1264

23/12/2025 09:22:14

1357029960589905

XLON


253

1266

23/12/2025 09:30:21

1357029960590280

XLON


69

1266

23/12/2025 09:33:33

1357029960590420

XLON


109

1268

23/12/2025 10:09:27

1357029960592702

XLON


14

1268

23/12/2025 10:09:27

1357029960592703

XLON


4

1268

23/12/2025 10:09:27

1357029960592704

XLON


2

1268

23/12/2025 10:09:27

1357029960592705

XLON


135

1268

23/12/2025 10:16:11

1357029960593040

XLON


6

1268

23/12/2025 10:16:11

1357029960593041

XLON


37

1268

23/12/2025 10:16:11

1357029960593042

XLON


238

1266

23/12/2025 10:43:08

1357029960594394

XLON


92

1266

23/12/2025 10:55:28

1357029960595026

XLON


40

1266

23/12/2025 10:59:19

1357029960595334

XLON


96

1266

23/12/2025 10:59:19

1357029960595335

XLON


6

1266

23/12/2025 11:15:47

1357029960596290

XLON


52

1266

23/12/2025 11:47:50

1357029960597610

XLON


42

1266

23/12/2025 11:47:50

1357029960597611

XLON


13

1268

23/12/2025 11:58:34

1357029960597960

XLON


83

1268

23/12/2025 11:58:34

1357029960597961

XLON


28

1268

23/12/2025 11:58:34

1357029960597962

XLON


27

1268

23/12/2025 12:11:34

1357029960598499

XLON


19

1268

23/12/2025 12:11:34

1357029960598500

XLON


6

1268

23/12/2025 12:11:34

1357029960598501

XLON


6

1268

23/12/2025 12:11:34

1357029960598502

XLON


28

1268

23/12/2025 12:13:13

1357029960598556

XLON


6

1268

23/12/2025 12:13:13

1357029960598557

XLON


467

1274

23/12/2025 12:47:36

1357029960600350

XLON


220

1274

23/12/2025 12:47:36

1357029960600353

XLON


181

1274

23/12/2025 12:47:36

1357029960600354

XLON


2

1274

23/12/2025 12:47:36

1357029960600355

XLON


21

1272

23/12/2025 13:19:14

1357029960601874

XLON


6

1272

23/12/2025 13:19:14

1357029960601875

XLON


82

1272

23/12/2025 13:23:40

1357029960602091

XLON


4

1272

23/12/2025 13:27:00

1357029960602210

XLON


12

1272

23/12/2025 13:27:00

1357029960602211

XLON


348

1270

23/12/2025 13:32:00

1357029960602503

XLON


177

1270

23/12/2025 13:32:00

1357029960602504

XLON


483

1274

23/12/2025 14:33:34

1357029960607739

XLON


483

1274

23/12/2025 14:33:35

1357029960607744

XLON


359

1272

23/12/2025 14:34:59

1357029960607934

XLON


135

1272

23/12/2025 14:34:59

1357029960607935

XLON


192

1272

23/12/2025 14:43:34

1357029960609137

XLON


192

1272

23/12/2025 14:43:34

1357029960609138

XLON


31

1272

23/12/2025 14:43:34

1357029960609139

XLON


161

1272

23/12/2025 14:43:34

1357029960609140

XLON


31

1272

23/12/2025 14:43:34

1357029960609141

XLON


192

1272

23/12/2025 14:43:34

1357029960609142

XLON


192

1272

23/12/2025 14:43:34

1357029960609143

XLON


192

1272

23/12/2025 14:43:34

1357029960609144

XLON


192

1272

23/12/2025 14:43:34

1357029960609145

XLON


192

1272

23/12/2025 14:43:34

1357029960609146

XLON


192

1272

23/12/2025 14:43:34

1357029960609147

XLON


192

1272

23/12/2025 14:43:34

1357029960609148

XLON


192

1272

23/12/2025 14:43:34

1357029960609149

XLON


192

1272

23/12/2025 14:43:34

1357029960609150

XLON


192

1272

23/12/2025 14:43:34

1357029960609151

XLON


192

1272

23/12/2025 14:43:34

1357029960609152

XLON


192

1272

23/12/2025 14:43:34

1357029960609153

XLON


192

1272

23/12/2025 14:43:34

1357029960609154

XLON


192

1272

23/12/2025 14:43:34

1357029960609155

XLON


192

1272

23/12/2025 14:43:34

1357029960609156

XLON


192

1272

23/12/2025 14:43:34

1357029960609157

XLON


192

1272

23/12/2025 14:43:34

1357029960609158

XLON


192

1272

23/12/2025 14:43:34

1357029960609159

XLON


192

1272

23/12/2025 14:43:34

1357029960609160

XLON


192

1272

23/12/2025 14:43:34

1357029960609161

XLON


192

1272

23/12/2025 14:43:34

1357029960609162

XLON


192

1272

23/12/2025 14:43:34

1357029960609163

XLON


169

1272

23/12/2025 14:43:34

1357029960609164

XLON


122

1268

23/12/2025 14:57:32

1357029960611170

XLON


40

1268

23/12/2025 15:04:17

1357029960612176

XLON


29

1268

23/12/2025 15:04:17

1357029960612177

XLON


114

1268

23/12/2025 15:04:17

1357029960612178

XLON


117

1268

23/12/2025 15:18:26

1357029960613994

XLON


61

1268

23/12/2025 15:19:49

1357029960614171

XLON


120

1268

23/12/2025 15:28:14

1357029960615214

XLON


165

1268

23/12/2025 15:28:14

1357029960615216

XLON


68

1268

23/12/2025 15:34:27

1357029960615858

XLON


146

1268

23/12/2025 16:07:44

1357029960619867

XLON


24

1268

23/12/2025 16:11:14

1357029960620474

XLON


8

1270

23/12/2025 16:24:32

1357029960622797

XLON


23

1270

23/12/2025 16:24:32

1357029960622798

XLON


5

1270

23/12/2025 16:24:32

1357029960622799

XLON


24

1270

23/12/2025 16:24:32

1357029960622800

XLON


8

1270

23/12/2025 16:24:32

1357029960622801

XLON


 

 

Contacts

CVS Group plc                                                                                                                                                 via Camarco

Richard Fairman, CEO

Robin Alfonso, CFO

Paul Higgs, Chief Veterinary Officer

Charlotte Page, Head of Investor Relations

 

Peel Hunt LLP (Nominated Adviser & Joint Broker)                                                                                  +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark

 

Berenberg (Joint Broker)                                                                                                                             +44 (0)20 3207 7800

Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing

 

Camarco (Financial PR)                                                                                                                            cvsg@camarco.co.uk

Ginny Pulbrook                                                                                                                                                +44 (0)7961 315 138

Letaba Rimell

Tilly Butcher

 

About CVS Group plc (www.cvsukltd.co.uk)

 

CVS Group is an AIM-listed provider of veterinary services with operations in the UK and Australia.  CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

 

The Group now operates c.470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business ("Animed Direct").

 

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

CVS Group (CVSG)
UK 100

Latest directors dealings